Novascreen biosciences

Start Date End Date Funded Value Relevance

CSV

25 50 100

£689,479

Apr 13 - Dec 14

NANOHAT: Development of a safer and more effective sleeping sickness drug.

MRC award to King's College London and Sarah Thomas

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}